With regard to ACE2 and allergy patients, studies with controversial results have been published, some showing that allergy respiratory patients have reduced ACE2 expression in airway cells (Jackson et al., 2020) or indicating that IL-13 in allergic rhinitis and asthma patients significantly reduced ACE2 (Bradding et al., 2020). Here, IL13 is linked to allergic disease.